Abstract:AIM Female sex hormones are known to exert a protective role on the vascular endothelial function, but the exact mechanisms of such protection is not known. We aimed to study the possible regulatory role of the female sex hormones changes during the normal menstrual cycle on soluble adhesion molecules E-selectin and ICAM-1, plasma homocyteine, free radical markers and lipoproteins in healthy young women. METHODS EXPERIMENTAL DESIGN a cross sectional study of healthy female volunteers studied during a single normal menstrual cycle at 3 specific time points. SETTING North Staffordshire Hospitals NHS Trust. SUBJECTS 20 healthy young menstruating women, aged (mean +/- SEM) 34 +/- 1 years, with normal menstruation, defined as a menstrual cycle of 21-35 days were studied at 3 time points of the same menstrual cycle. First in the early follicular phase (M-phase), at mid-follicular phase (F-phase), and during the luteal phase (L-phase). INTERVENTION none. MEASUREMENT serum levels of soluble E-selectin, ICAM-1, plasma homocysteine, vitamin E and malondialdehyde (MDA), as well as lipoprotein fractions were measured at each time points. RESULTS The mean percentage change for E-selectin between the M-phase and L-phase, F-phase and L-phase were 6% and 4%, respectively, p<0.005, p<0.066. Levels of ICAM-1, vitamin E and malondialdehyde did not vary through the cycle. Homocysteine was not different between M-phase and F-phase (10.39 +/- 0.68 micromol/l vs 10.33 +/- 0.65), nor between M-phase and L-phase (10.39+/-0.68 vs 9.77 +/- 0.75 micromol/l). Although the mean percentage decrease in homocysteine between F- and L-phases was significant (5.36 +/- 0.53%, p=0.029), the absolute decrease in concentrations was not (p=0.07). There were no cyclical changes in total, LDL, HDL cholesterol, triglycerides, apo A-I, apo B or Lp(a). Using a linear regression model, after correction for age, smoking, body mass index (BMI) and waist/hip ratio (WHR), oestrogen levels were the only predictor of E-selectin during the L-phase p<0.005. There were no significant correlations between oestrogen with lipids, apolipoproteins or homocysteine. There was an interesting significant univariate correlation between homocysteine with low-density-lipoprotein (LDL) cholesterol and apo B throughout all phases of the cycle, which persisted after correction for the effects of age, BMI, WHR and smoking history. Multiple regression analysis with all these factors showed homocysteine to be a significant predictor of apo B concentration during M (p=0.030) and L-phases (p=0.023) of the cycle and of LDL cholesterol in the M-phase (p=0.033). CONCLUSION Female sex hormones may have small, though significant modulating role on E-selectin and homocysteine metabolism in healthy premenopausal women. Furthermore, the correlation between homocysteine, LDL and apo B levels suggests that induction of cholesterol synthesis by homocysteine, shown previously in vitro, may be of relevance in vivo.

The atherogenic index of plasma is increased by hormonal contraception

Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile

Association of contemporary hormonal contraception and the risk of arterial thrombosis

The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review

Cardiovascular Disease Incidence among Females in South Carolina by Type of Oral Contraceptives, 2000–2013: a Retrospective Cohort Study

Hormonal contraception in terms of effect on the hemostasis system

Hormonal Contraception and Risk of Cardiometabolic Disease in Women with HIV

Changes in Proteome Profiles Linked to Hormonal Contraceptive Use Among African American Women with untreated high blood pressure

Molecular Assessment of Pro-Adipogenic Effects for Common-Use Contraceptives and their Mixtures

Effects of hormonal contraceptives on lipid profile among women attending family planning unit in Goba Town Public Health Facilities, Bale, Southeast Ethiopia: a comparative cross-sectional study

Ischemic Stroke in Users of Combined Hormonal Contraceptives: A Danish Registry Study

EFFECT OF HORMONE REPLACEMENT THERAPY ON SERUM LIPOPROTEIN AND APOLIPOPROTEIN

Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions.

SAT463 Hormonal Contraceptive Use and Hypothyroidism Risk

Associations of hormonal contraceptives and infertility medications on the risk of venous thromboembolism, ischemic stroke, and cardiovascular disease in women

Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women

The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives

Effects of serum from oral contraceptive users on the metabolism of low density lipoprotein

Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment

Hypertriglyceridemia-Induced Acute Pancreatitis Exacerbated by Combined Oral Contraceptive Use: A Case Report

Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls